U6 small nuclear RNA 26, pseudogene (RNU6-26P)

RNU6-26P is a processed or unprocessed pseudogene derived from the U6 small nuclear RNA (U6 snRNA) gene family, located in the human genome. Unlike functional U6 snRNA genes, which encode a highly conserved non-coding RNA essential for the catalytic activity of the spliceosome during pre-mRNA splicing[1][2], pseudogenes such as RNU6-26P do not produce functional RNA transcripts and do not participate in splicing or other RNA processing functions. Pseudogenes arise through duplication or retrotransposition events[3], and while they may contribute to genome evolution or serve as genetic markers, they do not encode RNA or protein with biological activity. The U6 snRNA gene and pseudogenes are abundant in the vertebrate genome[2][3], but only functional copies contribute to spliceosome assembly and catalysis. RNU6-26P is not considered a molecular target for therapeutic intervention and does not have established links to disease or biomarker status. Key points from referenced material: - U6 snRNA is an essential component of the spliceosome and is highly conserved and functionally indispensable[1][2]. - Vertebrate genomes typically contain many copies of U6 snRNA genes and pseudogenes[2][3]. - Pseudogenes such as RNU6-26P do not produce active RNA and have no direct biological or disease role[3]. - Only functional U6 snRNA is involved in RNA splicing; pseudogenes are essentially “genomic fossils.” Summary: RNU6-26P is a pseudogene of the U6 snRNA gene, not a functional molecule or drug target; it has no biological function, no role in disease, and is not targeted by drugs or used as a biomarker[1][2][3].

Other names

RNU6-26RNU6-8RNU6-26P